Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
BMJ Open Diabetes Res Care ; 12(4)2024 Jul 18.
Artículo en Inglés | MEDLINE | ID: mdl-39025795

RESUMEN

INTRODUCTION: Diabetic polyneuropathy (DPN), a common complication of diabetes, can manifest as small, large, or mixed fiber neuropathy (SFN, LFN, and MFN, respectively), depending on the type of fibers involved. Despite evidence indicating small fiber involvement prior to large fiber involvement in type 1 diabetes mellitus (T1DM)-associated DPN, no evidence has been produced to determine the more prevalent subtype. We aim to determine the more prevalent type of nerve fiber damage-SFN, LFN, and MFN-in T1DM-associated DPN, both with and without pain. RESEARCH DESIGN AND METHODS: In this cross-sectional study, participants (n=216) were divided into controls; T1DM; T1DM with non-painful DPN (NP-DPN); and T1DM with painful DPN (P-DPN). DPN was further subgrouped based on neuropathy severity. The more prevalent type of fiber damage was determined applying small and large fiber-specific tests and three diagnostic models: model 1 (≥1 abnormal test); model 2 (≥2 abnormal tests); and model 3 (≥3 abnormal tests). RESULTS: MFN showed the highest prevalence in T1DM-associated DPN. No differences in neuropathy subtype were found between NP-DPN and P-DPN. DPN, with prevalent SFN plateaus between models 2 and 3. All models showed increased prevalence of MFN according to DPN severity. Model 3 showed increased DPN with prevalent LFN in early neuropathy. DPN with prevalent SFN demonstrated a similar, but non-significant pattern. CONCLUSIONS: DPN primarily manifests as MFN in T1DM, with no differentiation between NP-DPN and P-DPN. Additionally, we propose model 2 as an initial criterion for diagnosing DPN with a more prevalent SFN subtype in T1DM. Lastly, the study suggests that in mild stages of DPN, one type of nerve fiber (either small or large) is more susceptible to damage.


Asunto(s)
Diabetes Mellitus Tipo 1 , Neuropatías Diabéticas , Humanos , Diabetes Mellitus Tipo 1/complicaciones , Diabetes Mellitus Tipo 1/epidemiología , Neuropatías Diabéticas/epidemiología , Neuropatías Diabéticas/patología , Neuropatías Diabéticas/diagnóstico , Neuropatías Diabéticas/etiología , Masculino , Estudios Transversales , Femenino , Adulto , Persona de Mediana Edad , Fibras Nerviosas/patología , Prevalencia , Estudios de Casos y Controles , Estudios de Seguimiento , Conducción Nerviosa/fisiología , Pronóstico , Índice de Severidad de la Enfermedad
3.
Sci Rep ; 9(1): 15742, 2019 10 31.
Artículo en Inglés | MEDLINE | ID: mdl-31673100

RESUMEN

Wolfram syndrome (WS) is a rare neurodegenerative disorder that is mainly characterized by diabetes mellitus, optic nerve atrophy, deafness, and progressive brainstem degeneration. Treatment with GLP-1 receptor agonists has shown a promising anti-diabetic effect in WS treatment in both animal models and in human patients. Since previous research has tended to focus on investigation of the WS first symptom, diabetes mellitus, the aim of the present study was to examine liraglutide effect on WS-associated neurodegeneration. We took 9-month-old Wfs1 knock-out (KO) animals that already had developed glucose intolerance and treated them with liraglutide for 6 months. Our research results indicate that 6-month liraglutide treatment reduced neuroinflammation and ameliorated endoplasmic reticulum (ER) stress in the inferior olive of the aged WS rat model. Liraglutide treatment also protected retinal ganglion cells from cell death and optic nerve axons from degeneration. According to this, the results of the present study provide novel insight that GLP-1 receptor agonist liraglutide has a neuroprotective effect in the WS rat model.


Asunto(s)
Receptor del Péptido 1 Similar al Glucagón/agonistas , Liraglutida/uso terapéutico , Fármacos Neuroprotectores/uso terapéutico , Síndrome de Wolfram/tratamiento farmacológico , Animales , Apoptosis/efectos de los fármacos , Proteínas de Unión a Calmodulina/deficiencia , Proteínas de Unión a Calmodulina/genética , Modelos Animales de Enfermedad , Estrés del Retículo Endoplásmico/efectos de los fármacos , Prueba de Tolerancia a la Glucosa , Hiperglucemia/patología , Hiperglucemia/prevención & control , Liraglutida/farmacología , Masculino , Proteínas de la Membrana/deficiencia , Proteínas de la Membrana/genética , Neuronas/fisiología , Fármacos Neuroprotectores/farmacología , Nervio Óptico/metabolismo , Ratas , Ratas Transgénicas , Células Ganglionares de la Retina/citología , Células Ganglionares de la Retina/efectos de los fármacos , Células Ganglionares de la Retina/metabolismo , Síndrome de Wolfram/metabolismo , Síndrome de Wolfram/patología
4.
Pulm Circ ; 9(2): 2045894019848659, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30997866

RESUMEN

Cardiac fibrosis contributes to the development of heart failure in pulmonary hypertension. We aimed to assess the development of fibrosis and the effects of treatment with the anti-fibrotic agent pirfenidone in pressure overload induced right ventricular (RV) failure. Wistar rat weanlings were randomized to pulmonary trunk banding (PTB) or sham surgery. One week after the procedure, PTB rats were randomized into two groups with either six weeks on standard chow or treatment with pirfenidone mixed in chow (700 mg/kg/day). RV hemodynamic effects were evaluated by echocardiography, cardiac magnetic resonance imaging (MRI), and pressure-volume measurements. Sections from the isolated RV, left ventricle, and septum were sampled systematically; stereological point grids and the nucleator were used to estimate volume of fibrosis and cardiac hypertrophy, respectively. PTB caused RV failure in all rats subjected to the procedure. The volume fraction of fibrosis in the RV increased threefold in PTB rats corresponding to a sixfold increase in total volume of RV fibrosis. Volume fraction of fibrosis and total volume of fibrosis also increased in the septum and in the left ventricle. Pirfenidone reduced body weight but did not improve RV hemodynamics or reduce cardiac fibrosis. RV cardiomyocyte profile area was increased twofold in PTB rats without any effect of pirfenidone. RV pressure overload after PTB induced not only RV but also septal and left ventricular fibrosis assessed by stereology. Treatment with pirfenidone reduced body weight but did not reduce the development of cardiac fibrosis or delay the progression of RV failure.

5.
Eur J Histochem ; 62(1): 2859, 2018 Jan 29.
Artículo en Inglés | MEDLINE | ID: mdl-29569872

RESUMEN

Hepatocellular carcinoma is the third leading cause of cancer-related death worldwide and late diagnosis is the main cause of death in HCC patients. In this study expression patterns of HSP70, GPC3 and GS and their relationships with pathogenesis of HCC in Iranian patients were investigated. The expression of HSP70, GPC3 and GS were determined by immunohistochemistry and quantitative real-time PCR (q-PCR) methods, using 121 cases from patients with HBV alone, HCC without HBV, HBV+HCC and 30 normal tissues as control group. HSP70, GPC3 and GS were expressed in higher levels in HBV-related HCC samples compared to HBV alone group. The results showed that the labeling index of HSP70, GPC3 and GS are correlated with immunohistochemical and molecular expressions of HSP70, GPC3 and GS. The sensitivity and specificity for HCC diagnosis were 43.4% and 89.7% for HSP70, 64.3% and 90.4% for GPC3, and 60.7% and 94.3% for GS, respectively. The sensitivity and specificity of the panels with 3, 2 and 1 positive markers, regardless of which one, were 21.6% and 100%, 51.3% and 100% and 93.4% and 80.5% respectively. The current study demonstrated an association between HSP70, GPC3 and GS expressions and HBV-related HCC in our population. It was concluded that HSP70, GPC3 and GS expressions could be useful biomarkers for increasing the specificity and sensitivity of HCC diagnosis to acceptable level. Also, proper combinations of these 3 markers could improve diagnostic accuracy.


Asunto(s)
Carcinoma Hepatocelular/diagnóstico , Glipicanos/metabolismo , Proteínas HSP70 de Choque Térmico/metabolismo , Hepatitis B Crónica , Neoplasias Hepáticas/diagnóstico , Adulto , Biomarcadores de Tumor , Femenino , Glipicanos/genética , Proteínas HSP70 de Choque Térmico/genética , Humanos , Inmunohistoquímica , Masculino , Persona de Mediana Edad , Reacción en Cadena de la Polimerasa , Estándares de Referencia , Factores de Riesgo , Sensibilidad y Especificidad
6.
Mediators Inflamm ; 2015: 120605, 2015.
Artículo en Inglés | MEDLINE | ID: mdl-26696749

RESUMEN

Intestinal CD4(+) T cell depletion is rapid and profound during early HIV-1 infection. This leads to a compromised mucosal barrier that prompts chronic systemic inflammation. The preferential loss of intestinal T helper 17 (Th17) cells in HIV-1 disease is a driver of the damage within the mucosal barrier and of disease progression. Thus, understanding the effects of new therapeutic strategies in the intestines has high priority. Histone deacetylase (HDAC) inhibitors (e.g., panobinostat) are actively under investigation as potential latency reversing agents in HIV eradication studies. These drugs have broad effects that go beyond reactivating virus, including modulation of immune pathways. We examined colonic biopsies from ART suppressed HIV-1 infected individuals (clinicaltrials.gov: NCT01680094) for the effects of panobinostat on intestinal T cell activation and on inflammatory cytokine production. We compared biopsy samples that were collected before and during oral panobinostat treatment and observed that panobinostat had a clear biological impact in this anatomical compartment. Specifically, we observed a decrease in CD69(+) intestinal lamina propria T cell frequency and increased IL-17A mRNA expression in the intestinal epithelium. These results suggest that panobinostat therapy may influence the restoration of mucosal barrier function in these patients.


Asunto(s)
Síndrome de Inmunodeficiencia Adquirida/inmunología , VIH-1 , Inhibidores de Histona Desacetilasas/farmacología , Ácidos Hidroxámicos/farmacología , Indoles/farmacología , Interleucina-17/genética , Mucosa Intestinal/inmunología , ARN Mensajero/análisis , Adulto , Regulación de la Expresión Génica , Humanos , Interferón gamma/biosíntesis , Activación de Linfocitos , Panobinostat , Linfocitos T/inmunología
7.
Basic Res Cardiol ; 103(1): 12-21, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18004633

RESUMEN

Voluntary exercise (VE) has a beneficial influence on the heart and mean lifespan. The present study evaluates structural adaptations of cardiomyocytes and their mitochondria due to VE by new, unbiased stereological methods. Female, 7-9-week-old mice were randomly assigned to a control (CG, n = 7) or VE group (EG, n = 7). EG animals were housed in cages with free access to a running wheel and had a mean running distance of 6.7 (1.8) km per day. After 4 weeks, the hearts of all mice were processed for light and electron microscopy. We estimated the number and volume of cardiomyocytes by the disector method and the number and volume of mitochondria by estimation of the Euler number. In comparison to CG, VE did not have an effect on the myocardial volume of the left ventricle (CG: 93 (10), EG: 103 (17) (mm(3))), the number of cardiomyocytes (CG: 2.81 (0.27), EG: 2.82 (0.43) (x10(6))) and their number-weighted mean volume. However, the composition of the cardiomyocytes changed due to VE. The total volume of mitochondria (CG: 21.8 (4.9), EG: 32.2 (4.3) (mm(3)), P < 0.01) and the total number (CG: 3.76 (0.44), EG: 7.02 (1.13) (x10(10)), P < 0.001) were significantly higher in EG than in CG. The mean number-weighted mitochondrial volume was smaller in EG than in CG (P < 0.05). In summary, VE does not alter ventricular volume nor cardiomyocyte volume or number but the oxidative capacity of cardiomyocytes by an increased mitochondrial number and total volume in the left ventricle. These structural changes may participate in the beneficial effects of VE.


Asunto(s)
Ventrículos Cardíacos/citología , Mitocondrias Cardíacas/fisiología , Miocitos Cardíacos/fisiología , Condicionamiento Físico Animal/fisiología , Animales , Femenino , Ventrículos Cardíacos/anatomía & histología , Ratones , Ratones Endogámicos C57BL , Microscopía Electrónica , Mitocondrias Cardíacas/ultraestructura , Miocitos Cardíacos/citología , Miocitos Cardíacos/ultraestructura , Tamaño de los Órganos , Distribución Aleatoria , Carrera/fisiología , Estadística como Asunto , Función Ventricular , Volición
8.
Anal Quant Cytol Histol ; 28(1): 54-60, 2006 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-16566280

RESUMEN

OBJECTIVE: The quantity of molecules can be measured very precisely by molecular biological methods, but the capabilities of these are limited to measure only the total mass of tissue. For estimating the number of molecules at the cell level, it is necessary to combine an immunohistochemical protocol with designed-based principles of stereology at the level of electron microscopy (EM). This article focuses on the problems and practical solutions of fitting together immunohistochemistry, stereology, and electron microscopy for the estimation of the number of angiotensin II AT1 receptors in rat kidney arterioles. STUDY DESIGN: We performed the preembedding immunostaining of angiotensin II AT1 receptors using the silver-enhanced immunogold labeling system at EM level on serial sections of renal arterioles from 5 rats. RESULTS: Using this method the number of molecules can be estimated along the renal arterioles separately on the cell's surface, in cytoplasm, in nucleus, or in any subcellular location. CONCLUSION: For estimating the number of AT1 receptors, we designed a protocol that took into account the requirements for both immuno-EM and stereology. This method can be applied for estimating any molecule number in different types of cells in tubules.


Asunto(s)
Arteriolas/anatomía & histología , Inmunohistoquímica/métodos , Glomérulos Renales/anatomía & histología , Túbulos Renales/irrigación sanguínea , Receptor de Angiotensina Tipo 1/química , Animales , Glomérulos Renales/química , Túbulos Renales/química , Masculino , Microscopía Electrónica de Rastreo , Ratas , Ratas Endogámicas WF
9.
J Assoc Res Otolaryngol ; 4(4): 505-20, 2003 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-14716509

RESUMEN

In general, postembryonic production of inner ear vestibular hair cells (HCs) is believed to occur in all nonmammalian vertebrates. However, no study on this topic has been published on reptiles and, consequently, it is not known whether this also applies to these vertebrates. Therefore, the present study applied stereological methods in order to estimate the total number of HCs in turtles of varying sizes. The findings are that in prehatchlings the utricular macula (UM) contains approximately 4000 HCs as compared to approximately 5000 in juveniles, approximately 8000 in medium-sized turtles, and approximately 12,000 in large, sexually mature turtles. Scanning electron microscopy (SEM) reveals that presumably newly generated HCs with small surface areas and thin stereovilli are found in all regions of the UM. Furthermore, it reveals that utricular HCs can be classified as belonging to a specific region from the morphology of their apical structure. Striolar HCs have a large free oval-to-ovoid surface, a hair bundle with numerous stereovilli, and a short kinocilium. Rampary and cotillary HCs have smaller and slimmer free surfaces, comparatively fewer stereovilli, but much longer kinocilia. In conclusion, the current study demonstrates that postembryonic production of HCs does occur in reptiles and thereby supports the general view that this is a common trait in all nonmammalian vertebrates.


Asunto(s)
Sáculo y Utrículo/citología , Sáculo y Utrículo/crecimiento & desarrollo , Tortugas/anatomía & histología , Factores de Edad , Animales , División Celular , Células Ciliadas Auditivas/ultraestructura , Microscopía Electrónica de Rastreo , Modelos Biológicos , Sáculo y Utrículo/embriología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA